Literature DB >> 25917182

[Acute kidney injury: choice of the initial modality for renal replacement therapy].

A Jörres1.   

Abstract

Continuous and intermittent renal replacement therapies are thought to be equally adequate approaches for the treatment of patients with acute kidney injury. Accordingly, current guidelines advocate the use of different modalities in a complementary fashion, i.e., to tailor therapy to the specific clinical situation. In patients with hemodynamic instability or at risk of cerebral edema, continuous renal replacement therapy or prolonged intermittent renal replacement therapy should, however, be preferred. Intermittent hemodialysis, on the other hand, remains the therapy of choice for the rapid correction of life-threatening electrolyte abnormalities or metabolic acidosis. During the further course of treatment, an individualized approach should be continued which may include a switch between modalities based on current therapeutic goals and potential risks for side effects of renal replacement therapy.

Entities:  

Mesh:

Year:  2015        PMID: 25917182     DOI: 10.1007/s00063-015-0024-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  19 in total

1.  Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial.

Authors:  Christophe Vinsonneau; Christophe Camus; Alain Combes; Marie Alyette Costa de Beauregard; Kada Klouche; Thierry Boulain; Jean-Louis Pallot; Jean-Daniel Chiche; Pierre Taupin; Paul Landais; Jean-François Dhainaut
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

Review 2.  Peritoneal dialysis for acute kidney injury.

Authors:  Brett Cullis; Mohamed Abdelraheem; Georgi Abrahams; Andre Balbi; Dinna N Cruz; Yaacov Frishberg; Vera Koch; Mignon McCulloch; Alp Numanoglu; Peter Nourse; Roberto Pecoits-Filho; Daniela Ponce; Bradley Warady; Karen Yeates; Fredric O Finkelstein
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

Review 3.  Renal replacement therapy in patients with acute renal failure: a systematic review.

Authors:  Neesh Pannu; Scott Klarenbach; Natasha Wiebe; Braden Manns; Marcello Tonelli
Journal:  JAMA       Date:  2008-02-20       Impact factor: 56.272

Review 4.  Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis.

Authors:  Sean M Bagshaw; Luc R Berthiaume; Anthony Delaney; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

5.  Platelet loss across the hemofilter during continuous hemofiltration.

Authors:  J Mulder; H K Tan; R Bellomo; W Silvester
Journal:  Int J Artif Organs       Date:  2003-10       Impact factor: 1.595

6.  Continuous hemofiltration and platelet function in critically ill patients.

Authors:  J Boldt; T Menges; M Wollbrück; S Sonneborn; G Hempelmann
Journal:  Crit Care Med       Date:  1994-07       Impact factor: 7.598

7.  Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure.

Authors:  Max Bell; Fredrik Granath; Staffan Schön; Anders Ekbom; Claes-Roland Martling
Journal:  Intensive Care Med       Date:  2007-03-16       Impact factor: 17.440

8.  The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*.

Authors:  Ron Wald; Salimah Z Shariff; Neill K J Adhikari; Sean M Bagshaw; Karen E A Burns; Jan O Friedrich; Amit X Garg; Ziv Harel; Abhijat Kitchlu; Joel G Ray
Journal:  Crit Care Med       Date:  2014-04       Impact factor: 7.598

9.  Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts.

Authors:  Vedat Schwenger; Markus A Weigand; Oskar Hoffmann; Ralf Dikow; Lars P Kihm; Jörg Seckinger; Nexhat Miftari; Matthias Schaier; Stefan Hofer; Caroline Haar; Peter P Nawroth; Martin Zeier; Eike Martin; Christian Morath
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

10.  Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.

Authors:  Andreas Link; Matthias Girndt; Simina Selejan; Ranja Rbah; Michael Böhm
Journal:  Crit Care       Date:  2008-08-29       Impact factor: 9.097

View more
  2 in total

1.  Hemofiltration induces generation of leukocyte-derived CD31+/CD41- microvesicles in sepsis.

Authors:  Georg Franz Lehner; Ulrich Harler; Clemens Feistritzer; Viktoria Maria Haller; Julia Hasslacher; Romuald Bellmann; Michael Joannidis
Journal:  Ann Intensive Care       Date:  2017-09-04       Impact factor: 6.925

2.  Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.

Authors:  Stephan Braune; Christina König; Jason A Roberts; Axel Nierhaus; Oliver Steinmetz; Michael Baehr; Stefan Kluge; Claudia Langebrake
Journal:  Crit Care       Date:  2018-01-30       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.